Cubic Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Cubic Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.34M	Hold	3,200	–	–	0.32%	80
2023 Q4	$1.3M	Hold	3,200	–	–	0.33%	76
2023 Q3	$1.11M	Hold	3,200	–	–	0.31%	82
2023 Q2	$1.13M	Hold	3,200	–	–	0.3%	82
2023 Q1	$1.01M	Hold	3,200	–	–	0.28%	86
2022 Q4	$924K	Hold	3,200	–	–	0.26%	89
2022 Q3	$927K	Hold	3,200	–	–	0.28%	84
2022 Q2	$902K	Hold	3,200	–	–	0.24%	89
2022 Q1	$835K	Hold	3,200	–	–	0.19%	113
2021 Q4	$703K	Hold	3,200	–	–	0.16%	124
2021 Q3	$580K	Hold	3,200	–	–	0.14%	129
2021 Q2	$645K	Hold	3,200	–	–	0.16%	125
2021 Q1	$688K	Hold	3,200	–	–	0.18%	114
2020 Q4	$756K	Hold	3,200	–	–	0.22%	99
2020 Q3	$871K	Hold	3,200	–	–	0.31%	70
2020 Q2	$929K	Hold	3,200	–	–	0.33%	72
2020 Q1	$761K	Hold	3,200	–	–	0.31%	76
2019 Q4	$701K	Hold	3,200	–	–	0.2%	100
2019 Q3	$542K	Hold	3,200	–	–	0.16%	115
2019 Q2	$587K	Hold	3,200	–	–	0.18%	111
2019 Q1	$589K	Hold	3,200	–	–	0.17%	107
2018 Q4	$530K	Hold	3,200	–	–	0.17%	107
2018 Q3	$617K	Hold	3,200	–	–	0.17%	114
2018 Q2	$544K	Hold	3,200	–	–	0.16%	119
2018 Q1	$522K	Hold	3,200	–	–	0.15%	118
2017 Q4	$480K	Hold	3,200	–	–	0.13%	126
2017 Q3	$487K	Hold	3,200	–	–	0.14%	127
2017 Q2	$412K	Hold	3,200	–	–	0.12%	133
2017 Q1	$350K	Hold	3,200	–	–	0.11%	147
2016 Q4	$236K	Buy	+3,200	New	+$260K	0.07%	160

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cubic Asset Management's VRTX Position: Q1 2024 in Review

Cubic Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2024 at 3,200 shares worth $1.34M. The position accounts for 0.32% of the portfolio, ranked #80.

Cubic Asset Management first reported a position in VRTX in Q4 2016 and has held it in 30 quarters since. 1,493 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

Cubic Asset Management held 3,200 shares of Vertex Pharmaceuticals worth $1.34M as of Q1 2024.
Cubic Asset Management left its Vertex Pharmaceuticals share count unchanged in Q1 2024.
Vertex Pharmaceuticals made up 0.32% of Cubic Asset Management's portfolio in Q1 2024, its #80 holding.
Cubic Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 30 quarters since.
1,493 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Cubic Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.